UTL-5g is primarily researched for its potential therapeutic applications, particularly in mitigating the adverse effects of chemotherapy. Studies suggest it may act as a chemoprotectant, reducing toxicity in healthy tissues while enhancing the efficacy of cancer treatments like cisplatin. It has shown promise in protecting against cisplatin-induced nephrotoxicity and hepatotoxicity, making it a candidate for improving patient outcomes during chemotherapy. Additionally, UTL-5g has been explored for its anti-inflammatory properties, potentially aiding in conditions involving chronic inflammation. Its role in modulating oxidative stress further supports its potential in treating diseases linked to cellular damage. Ongoing research aims to validate its safety and efficacy in clinical settings.